Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Sullivan

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Frontiers in Neuroscience|June 5, 2023
Multiple sclerosis lesion segmentation: revisiting weighting mechanisms for federated learningDongnan Liu, Mariano Cabezas, Dongang Wang, et al.
JCO Precision Oncology|June 29, 2018
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid TumorsAnshuman Panda, Anil Betigeri, Kalyanasundaram Subramanian, et al.
Pediatric Transplantation|July 16, 2017
Effect of thyroid hormone on cardiac function following orthotopic heart transplantation in pigletsT K Susheel Kumar, Craig Mathis, Shyam Sathanandam, et al.
Journal for Immunotherapy of Cancer|July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.
Clinical and Translational Science|June 20, 2024
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b studyJoaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, et al.
Pediatrics|November 9, 2011
Critically ill children during the 2009-2010 influenza pandemic in the United StatesAdrienne G Randolph, Frances Vaughn, Ryan Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic <i>BRAF</i>-Mutant MelanomaJean-Pierre Delord, Caroline Robert, Marta Nyakas, et al.
Melanoma Research|September 27, 2022
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case seriesJessica Louise Smith, Alexander M Menzies, Justine V Cohen, et al.
Science (New York, N.Y.)|July 28, 2012
Transforming fusions of FGFR and TACC genes in human glioblastomaDevendra Singh, Joseph Minhow Chan, Pietro Zoppoli, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective studyYana G Najjar, Kristina Navrazhina, Fei Ding, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Frontiers in Neuroscience|June 5, 2023
Multiple sclerosis lesion segmentation: revisiting weighting mechanisms for federated learningDongnan Liu, Mariano Cabezas, Dongang Wang, et al.
JCO Precision Oncology|June 29, 2018
Identifying a Clinically Applicable Mutational Burden Threshold as a Potential Biomarker of Response to Immune Checkpoint Therapy in Solid TumorsAnshuman Panda, Anil Betigeri, Kalyanasundaram Subramanian, et al.
Pediatric Transplantation|July 16, 2017
Effect of thyroid hormone on cardiac function following orthotopic heart transplantation in pigletsT K Susheel Kumar, Craig Mathis, Shyam Sathanandam, et al.
Journal for Immunotherapy of Cancer|July 13, 2018
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)Paolo A Ascierto, James Brugarolas, Luigi Buonaguro, et al.
Clinical and Translational Science|June 20, 2024
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of SAR439459, a TGFβ inhibitor, as monotherapy and in combination with cemiplimab in patients with advanced solid tumors: Findings from a phase 1/1b studyJoaquina C Baranda, Debbie Robbrecht, Ryan Sullivan, et al.
Pediatrics|November 9, 2011
Critically ill children during the 2009-2010 influenza pandemic in the United StatesAdrienne G Randolph, Frances Vaughn, Ryan Sullivan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic <i>BRAF</i>-Mutant MelanomaJean-Pierre Delord, Caroline Robert, Marta Nyakas, et al.
Melanoma Research|September 27, 2022
Neurological adverse effects associated with anti-PD1 antibodies alone or in combination with ipilimumab: a multicenter case seriesJessica Louise Smith, Alexander M Menzies, Justine V Cohen, et al.
Science (New York, N.Y.)|July 28, 2012
Transforming fusions of FGFR and TACC genes in human glioblastomaDevendra Singh, Joseph Minhow Chan, Pietro Zoppoli, et al.
Journal for Immunotherapy of Cancer|June 26, 2020
Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective studyYana G Najjar, Kristina Navrazhina, Fei Ding, et al.
Pageof 11